arrow
M

Marcus Bauer

university hospital halle
H指数:32
被引数:3,492

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunohistochemical profiling of the tumor microenvironment in Ethiopian breast cancer tissue: insights into pathology and subtypes

埃塞俄比亚乳腺癌组织中肿瘤微环境的免疫组织化学分析:对病理学和亚型的见解

2026-09-160
OAAI
An agentic framework for autonomous scientific discovery in cancer pathology

面向癌症病理自主科学发现的智能框架

2026-04-290
OAAI
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib

具有激活STAT5B突变的肝脾 γ δ T细胞淋巴瘤的临床前模型对JAK抑制剂upadacitinib敏感

2026-04-160
OAAI
Prospective validation of the prognostic and predictive impact of uPA/PAI-1 in early breast cancer

早期乳腺癌中uPA/PAI-1的预后和预测影响的预期验证

2025-12-080
OAAI
Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer

病理学家式可解释AI用于前列腺癌可解释的Gleason分级

2025-10-080
OAAI
Association of the composition of the bone marrow tumor microenvironment in BCR::ABL1-negative myeloproliferative neoplasms with IFN-γ signaling and driver mutations

BCR::ABL1阴性骨髓增殖性肿瘤中骨髓肿瘤微环境组成与IFN-γ信号通路及驱动基因突变的相关性

Leukemia
IF13.4
2025-08-050
OAAI
Artificial Intelligence-Based Single-Cell Analysis as a Next-Generation Histologic Grading Approach in Colorectal Cancer: Prognostic Role and Tumor Biology Assessment

基于人工智能的单细胞分析作为结直肠癌的下一代组织学分级方法:预后作用与肿瘤生物学评估

2025-07-010
OAAI
HIV status alters immune cell infiltration and activation profile in women with breast cancer

HIV状态改变了乳腺癌女性患者免疫细胞的浸润和活化特征。

2025-05-200
OA
UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer: A randomized multicenter phase 2 trial

UV1疫苗接种在经帕博利珠单抗治疗、患有复发性或转移性头颈癌患者中的效果:一项随机多中心II期临床试验

Med
IF11.8
2025-04-110
PRE
High prevalence of p16 staining in malignant tumors (vol 17, e0262877, 2022)

p16染色在恶性肿瘤中高表达 (vol 17, e0262877, 2022)

2025-01-240
OA
GrandQC: A comprehensive solution to quality control problem in digital pathology

GrandQC: 数字病理学质量控制问题的综合解决方案

2024-12-160
OAAI
Blood immune profiling of Ethiopian patients with breast cancer highlights different forms of immune escape

埃塞俄比亚乳腺癌患者的血液免疫分析突出了不同形式的免疫逃逸

2024-12-020
OA
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy
2024-11-290
OAAI
Immune landscape of the tumour microenvironment in Ethiopian breast cancer patients

埃塞俄比亚乳腺癌患者肿瘤微环境的免疫景观

2024-11-250
OAAI
PAM50 breast cancer subtypes and survival of patients in rural Ethiopia without adjuvant treatment: a prospective observational study

PAM50乳腺癌亚型与未接受辅助治疗的埃塞俄比亚农村患者的生存率: 一项前瞻性观察研究

2024-09-101
OAAI